Gynecologic Oncology Group (GOG) performance status 0, 1, 2
Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists; in general, this would refer to any active GOG Phase III protocol or Rare Tumor protocol for the same patient population
Patients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status > 2
Gynecologic Oncology Group (GOG) or Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky scale (KPS) =< 70%
Eastern Cooperative Oncology Group (ECOG) (World Health Organization [WHO]/Gynecologic Oncology Group [GOG]/Zubrod score) performance status 0 - 2
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status =< 2
PHASE I: Patients must have a Gynecologic Oncology Groups (GOG) performance status of 0, 1, or 2
Unlimited number of prior treatment lines, provided Gynecologic Oncology Group (GOG)/Eastern Cooperative Oncology Group (ECOG) status is 0-1
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0 or 1
Gynecologic Oncology Group (GOG) performance status =< 2
Gynecologic Oncology Group (GOG) Performance Status of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status >= 2
Gynecologic Oncology Group (GOG) performance status of 0 or 1
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0-1
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients with Gynecologic Oncology Group (GOG) performance status of 3 or 4
Gynecologic Oncology Group (GOG) performance status of 0 to 1.
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must not be eligible for a higher priority NRG clear cell protocol (Gynecologic Oncology Group [GOG]-0283); rare patients ineligible for GOG-0283 may be eligible for this trial without prior treatment on dasatinib therapy (e.g. they have been deemed allergic to dasatinib)
Gynecologic Oncology Group (GOG) performance status =< 2
Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists            \r\n* In general, this would refer to any active GOG phase III or rare tumor protocol for the same patient population
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Peritoneal dialysis catheter implantation is identical to that from the Gynecologic Oncology Group (GOG) 252 Protocol and revised from the GOG Surgical Procedures Manual
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patient must have Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status =< 2
